Overview of Dr. Trivedi
Dr. Meghna Trivedi is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Maryland School of Medicine and has been in practice 7 years. She is one of 379 doctors at New York-Presbyterian Hospital and one of 117 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
University of Maryland School of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2013 - 2026
PA State Medical License 2010 - 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 74 citationsRandomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancerHeather Greenlee, Katherine D. Crew, Jillian Capodice, Danielle Awad, Donna Buono
Breast Cancer Research and Treatment. 2016-03-25 - 22 citationsProgrammed death 1 immune checkpoint inhibitors.Meghna S. Trivedi, Brianna Hoffner, Jennifer L Winkelmann, Maura Abbott, Omid Hamid
Clinical Advances in Hematology & Oncology. 2015-12-01 - 3 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-09-14
Press Mentions
I-sPY2.2: Dato-DXd plus Durvalumab Yields High Pathologic Response Rate in Breast Cancer SubsetOctober 23rd, 2024- Breast Cancer: What to Know About Genetic TestingOctober 16th, 2024
- Cancer Prevention Strategies Linked to Mortality Reduction in BRCA CarriersMarch 6th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
